SCHEMBL1958016

SCHEMBL1958016

CCOC(=O)c1ccc(F)cc1F.CCOC(=O)c1ccc(F)cc1Oc1ccc2[nH]c(C)cc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.47
ALDH1A1 P00352 4/20 0.45
RAB9A P51151 3/20 0.45
HPGD P15428 3/20 0.45
NPC1 O15118 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
KDM4E B2RXH2 2/20 0.45
LMNA P02545 1/20 0.45
HTT P42858 1/20 0.45
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
MAPT P10636 2/20 0.43
TDP1 Q9NUW8 1/20 0.40
TSHR P16473 2/20 0.40
FLT3 P36888 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
AXL P30530 1/20 0.40
GAA P10253 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2502868 0.96 HPGD (0.48) SCN9AALDH1A1RAB9AHPGDNPC1
SCHEMBL1743409 0.86 KDR (0.49) SCN9AALDH1A1NPC1L3MBTL1MEN1
SCHEMBL1954871 0.81 JAK2 (0.46) ALDH1A1RAB9AHPGDNPC1L3MBTL1
SCHEMBL1744415 0.81 KDR (0.52) ALDH1A1RAB9AHPGDNPC1L3MBTL1
SCHEMBL1960348 0.78 TSHR (0.50) ALDH1A1RAB9AHPGDNPC1L3MBTL1
SCHEMBL367075 0.76 TSHR (0.57) ALDH1A1RAB9AHPGDNPC1L3MBTL1
SCHEMBL1957290 0.75 KDM4E (0.49) KDM4ELMNAHTTMEN1KMT2A
SCHEMBL1955771 0.74 HTR2A (0.52) SCN9ATSHR
SCHEMBL3498239 0.74 THRA (0.46) ALDH1A1RAB9AHPGDL3MBTL1LMNA
SCHEMBL1742275 0.74 SMN1; SMN2 (0.51) ALDH1A1L3MBTL1KDM4ELMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2507211-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2012-10-10 EP disclosed
WO-2011068560-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-06-09 WO disclosed